Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer CellsJesenia M. Perez(University of Minnesota), Stefani N. Thomas(University of Minnesota)International Journal of Molecular SciencesDecember 7, 202510.3390/ijms262411820Cited by 0SaveCiteExport RISWatch citationsRelated PapersIntegrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer|Cell|2016|1.1kIntegrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma|Cell Reports|2020|155